Event Timeline
| 11:30 AM - 01:00 PM |
|
Careers in Child Neurology: Ask the Experts
Brenda L. Banwell, MD, FAAN, Rujuta B. Wilson, MD, Shafali Jeste, MD, FAAN, Karen C. Keough, MD, Rebecca K. Lehman, MD, FAAN, Ann H. Tilton, MD, FAAN, David K. Urion, MD, FAAN
|
| 11:30 AM - 06:00 PM |
Abstract |
001 - Effects of Vagal Nerve Stimulation in Alternating Hemiplegia of Childhood
Alex Hillyer
|
| 11:30 AM - 06:00 PM |
Abstract |
002 - Clinical Metabolomic Profiling for the Diagnosis of Neurometabolic Disorders for Global Developmental Delay, Seizures
Meeta Wagle Cardon, MD
|
| 11:30 AM - 06:00 PM |
Abstract |
003 - Quantitative Effects of Botulinum Toxin Treatment on the Modified Ashworth Scale and the Tardieu Scale: Results from a Randomized Controlled Study of AbobotulinumtoxinA in Children with Dynamic Equinus Foot Deformity due to Cerebral Palsy
Ann H. Tilton, MD, FAAN
|
| 11:30 AM - 06:00 PM |
Abstract |
004 - Changes in the Microstructural Connectome Underlie Visual Memory Deficits in the Prematurely Born at Age 16 Years
Alyssa R. Thomas, BA
|
| 11:30 AM - 06:00 PM |
Abstract |
005 - Pediatric Sport-Related Concussion 好色先生: Effectiveness and Long-Term Retention of the Head Safety Youth Sports (HSYS) Program for Youth Athletes, Ages 11-16
Ross-Jordon Elliott
|
| 11:30 AM - 06:00 PM |
Abstract |
006 - Treatment of ADHD in Youth with Epilepsy
Michelle D. Lally, MD
|
| 11:30 AM - 06:00 PM |
Abstract |
007 - Quantification of Risks of Seizure in Autism
Jennifer L. Jaskiewicz, DO
|
| 11:30 AM - 06:00 PM |
Abstract |
008 - Results of North Star Ambulatory Assessments (NSAA) in the Phase 3 Ataluren Confirmatory Trial in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (ACT DMD)
Kate Bushby, MD
|
| 11:30 AM - 06:00 PM |
Abstract |
009 - Placental Pathology in Neonatal Stroke: A Retrospective Case-Control Study
Miya Bernson-Leung, MD
|
| 11:30 AM - 06:00 PM |
Abstract |
010 - Emotional Abuse History and Migraine among Young Adults: Results from The Add Health Dataset
Gretchen E. Tietjen, MD
|
| 11:30 AM - 06:00 PM |
Abstract |
011 - Treatment of Leukoencephalopathy with Cerebral Calcifications and Cysts with Bevacizumab: A Case Report
Alexander J. Fay, MD, PhD
|
| 11:30 AM - 06:00 PM |
Abstract |
012 - Maternal Illness in Pregnancy and Perinatal Exposure to Pesticides Are Associated with Risk for Pediatric Onset MS
Jennifer Graves, MD, PhD
|
| 11:30 AM - 06:00 PM |
Abstract |
013 - Predictors of Tic Severity in Post-Childhood Tourette Syndrome: Age-Gender Interaction and Comorbidities
David G. Lichter, FRACP, MBChB, FAAN
|
| 01:00 PM - 01:30 PM |
|
Overview of the Child Neurology Foundation’s Transition Project
Lawrence W. Brown, MD
|
| 01:30 PM - 02:00 PM |
|
Common Principles of Transition for the Child Neurology Team
Ann H. Tilton, MD, FAAN
|
| 02:00 PM - 02:30 PM |
|
Review of the Literature
Claudio M. DeGusmao, MD
|
| 02:30 PM - 03:00 PM |
|
How Can Adult Neurologists Support Successful Transitions?
Gregory D. Cascino, MD, FAAN
|
| 03:00 PM - 03:30 PM |
|
Break/Poster Viewing
|
| 03:30 PM - 05:00 PM |
|
Scientific Presentations
|
| 05:00 PM - 05:30 PM |
|
Poster Blitz Presentations
|
| 05:30 PM - 06:00 PM |
|
Networking Reception
|
Faculty Disclosures
| Lawrence W. Brown, MD |
Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving as a member. Data Safety Monitoring Board with Best Pharmaceuticals for Children Act (NIH). Dr. Brown has a non-compensated relationship as a member, Transition Practices Advisory Committee with Child Neurology Foundation that is relevant to AAN interests or activities. |
| Gregory D. Cascino, MD, FAAN |
Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. |
| David G. Lichter, FRACP, MBChB, FAAN |
No disclosure on file
|
| Laura R. Ment, MD |
No disclosure on file
|
| Mohamad A. Mikati, MD |
No disclosure on file
|
| Ann H. Tilton, MD, FAAN |
Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for allergan. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Dr. Tilton has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Keane law firm - Defense. |
| David K. Urion, MD, FAAN |
Dr. Urion has nothing to disclose. |
| Gretchen E. Tietjen, MD |
Dr. Tietjen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Tietjen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CME Outfitters. An immediate family member of Dr. Tietjen has stock in Johnson & Johnson. |
| Michael J. Rivkin, MD |
No disclosure on file
|
| Bianca Weinstock-Guttman, MD |
Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH. |
| Brenda L. Banwell, MD, FAAN |
Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH. |
|
No disclosure on file
|
| Tanuja Chitnis, MD, FAAN |
Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover. |
| Edward R. Dabrowski, MD |
Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solstice. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alergan. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Dabrowski has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Allergan. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Solstice. Dr. Dabrowski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alergan. The institution of Dr. Dabrowski has received research support from Ipsen. The institution of Dr. Dabrowski has received research support from Merz. |
| Sarah G. Finnegan, MD, PhD |
No disclosure on file
|
| Emmanuelle Waubant, MD, PhD, FAAN |
The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care. |
| Linda Leary, MD |
No disclosure on file
|
| Karen C. Keough, MD |
Dr. Keough has nothing to disclose. |
| Kate Bushby, MD |
Dr. Bushby has nothing to disclose. |
| Francesco Muntoni, MD |
Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee. |
| David H. Dennison, MD, FAAN |
No disclosure on file
|
| Shafali Jeste, MD, FAAN |
Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance. |
| Jennifer P. Rubin, MD |
Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Passage Bio. |
| Jorge Carranza, MD |
Dr. Carranza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IPSEN. Dr. Carranza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IPSEN. |
| Rebecca K. Lehman, MD, FAAN |
No disclosure on file
|
| Jennifer Graves, MD, PhD |
Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono. |
| Lisa T. Emrick, MD |
Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH. |
| Miya Bernson-Leung, MD |
An immediate family member of Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. The institution of Dr. Bernson-Leung has received research support from AAMC Northeast Group on 好色先生al Affairs. The institution of an immediate family member of Dr. Bernson-Leung has received research support from NIH. |
| Michelle D. Lally, MD |
No disclosure on file
|
| Sujay M. Kansagra, MD |
No disclosure on file
|
| Alexander J. Fay, MD, PhD |
Dr. Fay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Retrotope. Dr. Fay has received personal compensation in the range of $0-$499 for serving as a Consultant for Teladoc. Dr. Fay has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeglea. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Fay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curry Rockefeller Group. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspiro. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dwyer Hernandez. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gallagher Bassett. Dr. Fay has received research support from Sarepta. The institution of Dr. Fay has received research support from Preston-Werner Ventures. |
| Bardia Nourbakhsh, MD |
The institution of Dr. Nourbakhsh has received research support from Genentech. The institution of Dr. Nourbakhsh has received research support from national MS Society . The institution of Dr. Nourbakhsh has received research support from Department of Defense. The institution of Dr. Nourbakhsh has received research support from NIH. |
| Rujuta B. Wilson, MD |
Dr. Wilson has nothing to disclose. |
| Claudio M. DeGusmao, MD |
Dr. DeGusmao has nothing to disclose. |
| Jennifer L. Jaskiewicz, DO |
No disclosure on file
|
| Meeta Wagle Cardon, MD |
Dr. Wagle Cardon has nothing to disclose. |
| Andrea Boan, PhD, MSCR |
No disclosure on file
|
| Alex Hillyer |
No disclosure on file
|
| Allison King, MD |
No disclosure on file
|
| Alyssa R. Thomas, BA |
No disclosure on file
|
| Stuart Peltz |
No disclosure on file
|
| Tuyen Ong |
No disclosure on file
|
| Philippe Picaut |
No disclosure on file
|
| Ross-Jordon Elliott |
No disclosure on file
|
| Greg Mytyk |
No disclosure on file
|
| Todd Constable |
Todd Constable has nothing to disclose. |
| Sarah Elsea |
The institution of Sarah Elsea has received research support from NIH. The institution of Sarah Elsea has received research support from Speragen, Inc. The institution of Sarah Elsea has received research support from PTC Therapeutics, Inc. The institution of Sarah Elsea has received research support from PRISMS, Inc. The institution of Sarah Elsea has received research support from Warren Alpert Foundation. Sarah Elsea has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Sarah Elsea has received personal compensation in the range of $0-$499 for serving as a Reviewer with CDMRP-DOD. |
| Cheryl Lacadie |
No disclosure on file
|